Mileutis

Mileutis Overview

Mileutis is a bio-pharmaceutical company focused on the discovery, development, and commercialization of novel and biologically sourced, safe, and residual-free therapies for animal and human health. Mileutis has developed a line of biopharmaceuticals that are revolutionizing the way in which farmers and veterinarians treat a wide range of diseases. Mileutis’ first products are comprised of peptides and specific protein fragments that have a positive impact on body functions and conditions that influence health. These peptides act through an immune-modulatory effect, enabling the management of infectious and chronic diseases without the use of antibiotics, thereby reducing the use of antibiotics in animal and human healthcare. This will assist in overcoming the global threat of antimicrobial resistance (AMR) generated by, among other things, the overuse of antibiotics. The company's lead products are Imilac and Milac, which target the management, treatment, and prevention of mastitis in dairy cows. Mileutis's products aim to replace antibiotics in dairy farms, improve cow wellbeing, and provide additional and significant economic value to farmers by increasing milk yield and productivity.

Cumulative Funding Raised Over Time ($)

Latest News

May 28, 2024 · www.prnewswire.com

growth-positive

Yotvata Dairy Farm Invests in Mileutis to Improve Milk Quality

Mileutis, an Israeli biopharmaceutical company, has announced a significant investment and expanded collaboration with Yotvata Dairy. This partnership aims to redefine the dairy industry by implementing a cutting-edge management system that reduces antibiotic use, enhances milk quality, and boosts sustainability. Yotvata Dairy Farm will invest millions of New Israeli Shekels in Mileutis, supporting the use of Imilac™ therapy to replace antibiotics in dairy farms. The collaboration follows successful clinical trials demonstrating Imilac™s effectiveness in improving milk yield and quality while reducing greenhouse gas emissions. This initiative aligns with the broader industry goal of achieving carbon neutrality by 2050. The partnership is expected to generate significant revenue and represents a major step towards more sustainable dairy farming practices.

PartnersInvestment

Aug 11, 2023 · www.claytoncountyregister.com

Israeli Startup Mileutis Finds Antibiotic Replacement for Dairy Industry

Aug 8, 2023 · www.reuters.com

Israel's Mileutis trial shows better milk quality without antibiotics in cows

Aug 7, 2023 · www.startuphub.ai

growth-positive

Mileutis’ Clinical Trial Achieves Dramatic Reduction in Antibiotic Use and Enhanced Milk Quality in Dairy Cows

Mileutis, an Israeli biopharmaceutical company, has successfully completed a clinical trial demonstrating the efficacy of its product, Imilac™, in replacing antibiotics in dairy cows during the dry-off period. The trial, conducted across seven dairy farms in Israel, showed that Imilac™ not only substitutes antibiotics but also enhances milk nutritional characteristics, increasing milk yield and improving cow welfare. The product has been patented and is seen as a breakthrough in sustainable dairy farming. Mileutis collaborates with major dairy providers like Yotvata Dairy and Tnuva, aligning with sustainability goals and reducing antibiotic use by up to 90%. This development is expected to positively impact the dairy industry, consumers, and the environment by promoting healthier milk production.

CustomersPartners

Feb 8, 2023 · nocamels.com

growth-positive

Antibiotic Alternative: Today Cows, Tomorrow Humans?

Mileutis, an Israeli bio-pharmaceutical company, has developed a natural alternative to antibiotics for dairy farming. The product, Imilac, uses peptides extracted from milk to boost cows immune systems, reducing the need for antibiotics. The company claims that Imilac is safer and more effective than antibiotics, and could be a game changer for the dairy industry. The product is close to receiving the necessary approvals for widespread use. Despite likely being more expensive than antibiotics, the company argues that it will benefit farmers as cows given Imilac yield more milk.

CustomersPartnersInvestment

Funding

Team Members

3

Employees: 11-50

Web & Social Links

Locations

Golda Me'ir Street 7, Ness Ziona, Israel

Photos & Videos

7 item(s)

Mileutis Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info